The Three-Dimensional X-Ray Crystal Structure of HIV-1 Protease Complexed with a Hydroxyethylene Inhibitor
The aspartyl proteinase encoded within the genome of the type I human immunodeficiency virus (HIV-1 PR) is a valid and important target for the development of a therapeutic to treat HIV infections. Progress in this area has been rapid due to 1) the wealth of previous experience with other aspartyl proteinases and 2) the massive commitment by a large number of research groups worldwide. In this chapter we would like to discuss some of our efforts to develop a PR inhibitor by describing the structure of a complex between HIV-1 PR and a hydroxyethylene inhibitor. As a final note before continuing, we would like to acknowledge the significant contributions that Alex Wlodawer and his group have made to this field which have been important to the progress made not only by our group but by many others as well.
KeywordsHuman Immunodeficiency Virus Aspartyl Proteinase Welwyn Garden City Human Renin Orthorhombic Form
Unable to display preview. Download preview PDF.
- 3.M. Szelke, D. M. Jones, B. Atrash, A. Hallett and B. J. Leckie, Novel Transition-State Analogue Inhibitors of Renin, in: “Peptides: Structure and Function, Proceedings of the 8th American Symposium,” V. J. Hruby and D. H. Rich, Eds., Pierce Chemical, Rockford, IL, (1983).Google Scholar
- 5.A. L. Swain, M. M. Miller, J. Green, D. H. Rich, J. Schneider, S. B. H. Kent and A. Wlodawer, X-ray Crystallographic Structure of a Complex Between a Synthetic Protease of Human Immunodeficiency Virus 1 and a Subtrate-based Hydroxyethylamine Inhibitor, Proc. Nat. Acad. Sci., U.S.A. 87: 8805 (1990).CrossRefGoogle Scholar
- 6.P. M. D. Fitzgerald, B. M. McKeever, J. F. VanMiddlesworth, J. P. Springer, J. C. Heimbach, C.-T. Leu, W. K. Herber, R. A. F. Dixon and P. L. Darke, Crystallographic Analysis of a Complex Between HIV-1 Protease and Acetyl-Pepstatin at 2.0 Å Resolution, J. Biol. Chem. 265: 14209 (1990).PubMedGoogle Scholar
- 7.J. Erickson, D. J. Neidhart, J. VanDrie, D. J. Kempf, X. C. Wang, D. W. Norbeck, J. J. Plattner, J. W. Rittenhouse, M. Turon, N. Wideburg, W. E. Kohlbrenner, R. Simmer, R. Helfrich, D. A. Paul and M. Knigge, Design, Activity and 2.8 Å Crystal Structure of a C2 Symmetric Inhibitor Complexed to HIV-1 Protease, Science 249: 527 (1990).PubMedCrossRefGoogle Scholar